Skip to content
AwardedCzechiaGoodsCZK 22,113,495

Dodávky léků – Léčivá látka risankizumab – ATC L04AC18

Published
Published 20 May 2026
Deadline
Closed 22 June 2026

Overview

Fakultní Thomayerova nemocnice procured ongoing supplies of risankizumab (ATC L04AC18), an immunosuppressive medication, in two formulations: 360 mg injection solution and 600 mg infusion concentrate. The contract was awarded to AbbVie s.r.o. on 26 June 2026 for the full estimated value of 22,113,495 CZK.

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 22,113,495
Procedure
Open
Published
20 May 2026
Deadline
Closed
Classification (CPV)
Immunosuppressive agents

Award outcome

Awarded value
CZK 22,113,495
Award date
26 June 2026
Contract period
3 July 2026 → 12 June 2030
Winner
  • AbbVie s.r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    6 July 2026

  2. Contract Notice

    20 May 2026

Contracting authority

  • Fakultní Thomayerova nemocnice

    Procuring entity

    Praha, Czechia

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Dodávky léků – Léčivá látka risankizumab – ATC L04AC18 — won by AbbVie s.r.o. — Skim